Acasă › Cancer ovarian › New Jersey › Edison
Studii clinice pentru Cancer ovarian în Edison, NJ
20 studii pentru Cancer ovarian caută participanți în și în jurul orașului Edison (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
În curs de recrutareFaza 2/3
- Rutgers Cancer Institute of New Jersey, New Brunswick · La 3 mi distanță
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · La 15 mi distanță
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
În curs de recrutareFaza 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · La 3 mi distanță
- Robert Wood Johnson University Hospital Somerset, Somerville · La 11 mi distanță
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- START New Jersey, East Brunswick · La 6 mi distanță
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
În curs de recrutareFaza 1
- Research Site, New Brunswick · La 3 mi distanță
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
În curs de recrutareFaza 2
- Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick · La 3 mi distanță
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
În curs de recrutareFaza 2
- Research Site, East Brunswick · La 6 mi distanță
A Study of Isoquercetin in People With Ovarian Cancer
În curs de recrutareFaza 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · La 15 mi distanță
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- Astera Cancer Care, East Brunswick · La 6 mi distanță
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
În curs de recrutareFaza 1/2
- START New Jersey East Brunswick, East Brunswick · La 6 mi distanță
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
În curs de recrutareFaza 1
- START - New Jersey, East Brunswick · La 6 mi distanță
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
În curs de recrutareFaza 3
- Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick · La 3 mi distanță
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
În curs de recrutareFaza 1/2
- Start Njeb, East Brunswick · La 6 mi distanță
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- Rutgers Cancer Institute of New Jersey, New Brunswick · La 3 mi distanță
- Virtua Voorhees, Voorhees Township · La 5 mi distanță
- Robert Wood Johnson University Hospital Somerset, Somerville · La 11 mi distanță
- și încă 1
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- Rutgers Cancer Institute of New Jersey, New Brunswick · La 3 mi distanță
- Robert Wood Johnson University Hospital Somerset, Somerville · La 11 mi distanță
- Summit Medical Group, Berkeley Heights · La 11 mi distanță
- și încă 1
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
În curs de recrutare
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · La 15 mi distanță
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
În curs de recrutareFaza 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · La 15 mi distanță
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
În curs de recrutareFaza 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · La 15 mi distanță
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
În curs de recrutareFaza 2
- Rutgers Cancer Institute, New Brunswick · La 3 mi distanță
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, New Brunswick · La 3 mi distanță
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Exelixis Clinical Site #9, New Brunswick · La 3 mi distanță
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
Alte studii în Edison
- Cancer de sân68 studii
- Cancer pulmonar cu celule non-pătrate47 studii
- Cancer (toate tipurile)33 studii
- Cancer de prostată29 studii
- Cancer colorectal23 studii
- Cancer pulmonar23 studii
- Mielom multiplu22 studii
- Cancer de vezică urinară21 studii
- Leucemie mieloasă acută20 studii
- Cancer metastatic20 studii
- Cancer endometrial19 studii
- Carcinom urotelial (cu celule de tranziție)18 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.